Oatly Group AB | 6-K: Report of foreign private issuer (related to financial reporting)
Oatly Group AB | 6-K: Report of foreign private issuer (related to financial reporting)
Oatly Group AB | F-X: For appointment of agent for service of process by issuers registering securities
Oatly Group AB | CB: Certain tender offers, business combinations and rights offerings, in which the subject company is a foreign private issuer of which less than 10% of its securities are held by U.S. persons
Oatly Group AB | 144: Notice of proposed sale of securities pursuant to Rule 144
Oatly Group AB | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Oatly Group AB | 6-K: Report of foreign private issuer (related to financial reporting)
Oatly Group AB | 6-K: Report of foreign private issuer (related to financial reporting)
Oatly Group AB | 6-K: Report of foreign private issuer (related to financial reporting)
Oatly Group AB | 6-K: Report of foreign private issuer (related to financial reporting)
Oatly Group AB | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Oatly Group AB | EFFECT: Others
Oatly Group AB | F-6EF: Auto effective registration statement for American Depositary Receipts representing securities of certain foreign private issuers
Oatly Group AB | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Oatly Group AB | 20-F: Registration statement / Annual report / Transition report
Oatly Group AB | POSASR: Post-effective amendment to an automatic shelf registration statement on Form S-3ASR or Form F-3ASR
Oatly Group AB | 424B7: Prospectus
Oatly Group AB | 6-K: Report of foreign private issuer (related to financial reporting)
Oatly Group AB | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Blackstone Holdings II L.P.(8.1%),Blackstone Holdings I/II GP L.L.C.(8.1%), etc.
Oatly Group AB | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Nativus Company Limited(46.8%),CR Verlinvest Health Investment Limited (formerly known as “China Resources Verlinvest Health Investment Ltd.”)(46.8%), et
No Data